The ability of biomarkers to help predict response to treatment is one of their most powerful applications. New research on the response of breast cancer to tamoxifen has found a protein (cocaine-and-amphetamine-regulated transcript) that, when abundant, indicated that the patient was less likely to benefit from the drug. Using biomarkers to better target drug therapy can help avoid the unnecessary use of drugs, reduce side-effects, and lower costs.
